Optimizer System

DEVICE2 trials

Sponsors

Impulse Dynamics

Conditions

Heart Failure, CongestiveNYHA Class III Heart FailureNYHA Class IV Heart Failure

Unknown Phase

Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure: FIX-HF-5

CompletedNCT00112125

Impulse DynamicsHeart Failure, Congestive

Start: 2005-02-28End: 2019-03-19Updated: 2020-08-06

Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C

CompletedNCT01381172

Impulse DynamicsNYHA Class III Heart Failure, NYHA Class IV Heart Failure

Start: 2011-01-31End: 2019-03-19Updated: 2021-09-17

Related Papers

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

JACC Heart Failure2018-05-10255 citations

A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design.

2014-10-0533 citations